Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA FY 1999 goals

This article was originally published in The Tan Sheet

Executive Summary

FDA FY 1999 goals: Public reports from the Special Nutritionals Adverse Events Monitoring System will at least double in 1999 from the current two per year, FDA says in its FY 1999 budget justification. The agency notes it will "continue to respond to safety concerns associated with the rapidly expanding use and misuse of dietary supplement products such as ephedra." Regarding OTCs, FDA expresses its commitment to improving "the legibility and clarity of OTC drug labels" and "the consumer's ability to read and understand important warnings and usage directions." The President's budget request for FDA was issued Feb. 2 ("The Tan Sheet" Feb. 9, p. 15)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088183

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel